Titles
- Electronic prescribing of controlled substances and use of prescription drug monitoring programs among office-based physicians, 2019-20211
- Electronic public health reporting & recording of social & behavioral determinants of health among office-based physicians: 20191
- Electronic public health reporting among non-federal acute care hospitals during the COVID-19 pandemic, 20211
- Electronic submission of IND safety reports: technical conformance guide1
- Electronic submission template for medical device 510(k) submissions: guidance for industry and Food and Drug Administration staff1
- Eliminating access to no-cost preventive health services could affect more than 12 million adults ages 50 to 641
- Emergency care2
- Emerging practices for supporting LGBTQI+ young people across human services programs1
- Employment and material hardship among adults with long COVID in December 20221
- Employment outcomes for Social Security Disability Insurance applicants who use opioids1
- Empowered direct care worker: lessons from the Green House staffing model1
- End-of-life issues1
- Enforcement and compliance1
- Enforcement policy for certain supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) submissions: guidance for industry and Food and Drug Administration staff1
- Enforcement policy for clinical electronic thermometers: guidance for industry and Food and Drug Administration staff1
- Enforcement policy for face masks and barrier face coverings during the coronavirus disease (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff1
- Enforcement policy for face shields, surgical masks, and respirators during the coronavirus disease (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff1
- Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring: guidance for industry and Food and Drug Administration staff1
- Enhanced drug distribution security at the package level under the Drug Supply Chain Security Act: guidance for industry1
- Enhancing data infrastructure to improve women’s health outcomes1